0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover106.55%IV-37.45%PremiumJan 17, 2025Expiry Date4.49Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9711Delta0.0206Gamma2.64Leverage Ratio-0.0053Theta0.0045Rho2.56Eff Leverage0.0020Vega
Indivior Stock Discussion
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...
No comment yet